The human DEK oncogene was first reported to be the target of a recurrent t(6;9) translocation that generates a fusion protein with the nucleoporin CAN in a subset of patients with acute myeloid leukemia (AML) 20, 21. Here, DEK is linked to acute myeloid leukemia.